NeoGenomics Inc. [NASDAQ: NEO] stock went on a downward path that fall over -6.18% on Thursday, amounting to a one-week price decrease of less than -5.89%. Over the last 12 months, NEO stock rose by 13.30%. The one-year NeoGenomics Inc. stock forecast points to a potential upside of 22.52. The average equity rating for NEO stock is currently 1.50, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $2.86 billion, with 104.48 million shares outstanding and 105.28 million shares in the current float. Compared to the average trading volume of 1.12M shares, NEO stock reached a trading volume of 1212591 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Guru’s Opinion on NeoGenomics Inc. [NEO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NEO shares is $33.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NEO stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stephens have made an estimate for NeoGenomics Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 21, 2020. While these analysts kept the previous recommendation, Craig Hallum raised their target price to Buy. The new note on the price target was released on March 02, 2020, representing the official price target for NeoGenomics Inc. stock. On January 23, 2020, analysts increased their price target for NEO shares from 29 to 35.
The Average True Range (ATR) for NeoGenomics Inc. is set at 1.17, with the Price to Sales ratio for NEO stock in the period of the last 12 months amounting to 6.82. The Price to Book ratio for the last quarter was 5.36, with the Price to Cash per share for the same quarter was set at 0.78.
NEO Stock Performance Analysis:
NeoGenomics Inc. [NEO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.89. With this latest performance, NEO shares dropped by -3.74% in over the last four-week period, additionally sinking by -2.01% over the last 6 months – not to mention a rise of 13.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NEO stock in for the last two-week period is set at 41.28, with the RSI for the last a single of trading hit 36.68, and the three-weeks RSI is set at 44.74 for NeoGenomics Inc. [NEO]. The present Moving Average for the last 50 days of trading for this stock 27.52, while it was recorded at 27.33 for the last single week of trading, and 26.47 for the last 200 days.
Insight into NeoGenomics Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and NeoGenomics Inc. [NEO] shares currently have an operating margin of +3.96 and a Gross Margin at +43.05. NeoGenomics Inc.’s Net Margin is presently recorded at +1.96.
Return on Total Capital for NEO is now 3.02, given the latest momentum, and Return on Invested Capital for the company is 1.53. Return on Equity for this stock inclined to 1.93, with Return on Assets sitting at 1.32. When it comes to the capital structure of this company, NeoGenomics Inc. [NEO] has a Total Debt to Total Equity ratio set at 26.19. Additionally, NEO Total Debt to Total Capital is recorded at 20.75, with Total Debt to Total Assets ending up at 18.73. Long-Term Debt to Equity for the company is recorded at 23.46, with the Long-Term Debt to Total Capital now at 18.60.
Reflecting on the efficiency of the workforce at the company, NeoGenomics Inc. [NEO] managed to generate an average of $4,709 per employee. Receivables Turnover for the company is 4.75 with a Total Asset Turnover recorded at a value of 0.67.NeoGenomics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.90 and a Current Ratio set at 3.20.
NEO Stock EPS
With the latest financial reports released by the company, NeoGenomics Inc. posted 0.07/share EPS, while the average EPS was predicted by analysts to be reported at 0.06/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 16.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NEO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for NeoGenomics Inc. go to 20.00%.